NPC1L1 and colitis: Interestingly, NPC1L1 knockout mice showed protective effects against colitis-associated tumorigenesis by decreasing plasma lipids, especially cholesterol, to reduce inflammation and β-catenin, p-c-Jun, and p-ERK signaling [41].